Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Targeting An Untapped Female Sexual Dysfunction Drug Market
Targeting An Untapped Female Sexual Dysfunction Drug Market
Targeting An Untapped Female Sexual Dysfunction Drug Market
Submitted by
admin
on September 3, 2013 - 11:23am
Source:
Seeking Alpha
News Tags:
female sexual dysfunction
Osphena
Shionogi
flibanserin
Sprout Pharmaceuticals
bremelanotide
Palatin
Femprox
Apricus Biosciences
Headline:
Targeting An Untapped Female Sexual Dysfunction Drug Market
Do Not Allow Advertisers to Use My Personal information
